US trial with leriglitazone to commence in mid-2023 providing an FDA-approved route to US market
Adam Levy will be giving a presentation at the Jefferies Healthcare Conference at 9:30 a.m. ET June 9th 2023
Strengthening of strategic option license agreement to cover additional novel ADC targets
Funding to obtain IND approval for its lead compound VMX-C001 and to complete preparations for the pivotal clinical trial
Leading medical oncologist and seasoned biotechnology executive with significant experience in drug development
The study is designed to investigate the safety and efficacy of GB0139 in patients with IPF
First oral presentation on SPVN20 in a major scientific and medical conference
Commenced patient dosing in lorundrostat pivotal clinical program, for the treatment of patients with uncontrolled or resistant hypertension in April 2023
Elisabet de los Pinos, will participate in a fireside chat at the JMP Securities Life Sciences Conference
U.S. Food and Drug Administration (FDA) Guidance in Type C Meeting Supports Global Phase 3 Trial in Early-stage Choroidal Melanoma
Subscribe to our weekly newsletter for the latest updates on life sciences investments.